Patient, parent, person, research subject
Linnea Olson |
• November 2019
First in human trials are a necessary and important aspect of drug development. And for some patients, they are also the best and sometimes only treatment option. However, participation comes with a high cost. We’re clinical trials viewed through a different lens—one that placed an emphasis on humanity—many if the current barriers to participation could be addressed.